|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.03 EUR | +1.72% |
|
+4.02% | +9.46% |
| 25/06 | Cooler PCE, Hotter Chips |  |
| 25/06 | Bernstein: GSK Poised for Sustainable Growth Amid 'Much More Durable' HIV Franchise; Price Target, Forecasts Up | MT |
| Market Cap | 79.04B 104B 91.74B 84.53B 148B 9,855B 151B 1,014B 393B 4,858B 392B 384B 16,883B | P/E 2026 * |
12.6x | P/E 2027 * | 11.4x |
|---|---|---|---|---|---|
| Enterprise Value | 93.29B 123B 108B 99.77B 175B 11,633B 178B 1,197B 464B 5,734B 463B 453B 19,928B | EV / Sales 2026 * |
2.76x | EV / Sales 2027 * | 2.54x |
| Free-Float |
92.29% | Yield 2026 * |
3.53% | Yield 2027 * | 3.69% |
Last Transcript: GSK plc
| 1 day | +1.72% | ||
| 1 week | +4.02% | ||
| Current month | +5.89% | ||
| 1 month | +3.09% | ||
| 3 months | -2.87% | ||
| 6 months | +10.88% | ||
| Current year | +9.46% |
| 1 week | 22.07 |  | 23.08 |
| 1 month | 20.9 | | 23.28 |
| Current year | 20.34 | | 26.14 |
| 1 year | 15.32 | | 26.14 |
| 3 years | 14.48 | | 26.14 |
| 5 years | 14.48 | | 27.23 |
| 10 years | 14.48 | | 27.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
Luke Miels
CEO | Chief Executive Officer | - | 01/01/2026 |
Julie Brown
DFI | Director of Finance/CFO | 64 | 01/05/2023 |
| Chief Tech/Sci/R&D Officer | - | 01/12/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Luke Miels
BRD | Director/Board Member | - | 06/05/2026 |
Hal Barron
BRD | Director/Board Member | 64 | 01/01/2018 |
Jonathan Symonds
CHM | Chairman | 68 | 01/09/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.72% | +4.02% | - | - | 102B | |
| +0.93% | +2.65% | +42.33% | +145.77% | 996B | |
| +1.61% | +7.22% | +60.81% | +47.98% | 580B | |
| +3.51% | +12.31% | +31.15% | +78.88% | 415B | |
| +0.99% | +5.11% | +29.26% | +21.27% | 326B | |
| +1.09% | +6.90% | +37.22% | +23.11% | 284B | |
| +1.34% | +6.74% | +32.63% | +38.93% | 280B | |
| +1.32% | +12.69% | -27.48% | -42.00% | 210B | |
| +0.40% | +4.51% | +25.85% | +55.35% | 190B | |
| -1.05% | +0.06% | +16.91% | +59.86% | 155B | |
| Average | +1.19% | +5.12% | +27.63% | +47.68% | 381.86B | |
| Weighted average by Cap. | +1.33% | +4.81% | +35.33% | +70.19% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 33.8B 44.66B 39.23B 36.15B 63.39B 4,214B 64.55B 434B 168B 2,077B 168B 164B 7,219B | 35.5B 46.91B 41.2B 37.96B 66.57B 4,426B 67.79B 455B 176B 2,182B 176B 172B 7,582B |
| Net income | 6.48B 8.57B 7.53B 6.93B 12.16B 808B 12.38B 83.19B 32.22B 399B 32.17B 31.47B 1,385B | 7.02B 9.28B 8.15B 7.51B 13.17B 876B 13.41B 90.13B 34.91B 432B 34.86B 34.09B 1,500B |
| Net Debt | 14.25B 18.83B 16.54B 15.24B 26.73B 1,777B 27.22B 183B 70.84B 876B 70.73B 69.18B 3,044B | 11.19B 14.79B 12.99B 11.97B 20.99B 1,395B 21.37B 144B 55.61B 688B 55.53B 54.31B 2,390B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/06/26 | EUR 23.03 | +1.72% | 71,399 |
| 24/06/26 | EUR 22.64 | -0.18% | 71,997 |
| 23/06/26 | EUR 22.68 | +1.61% | 43,055 |
| 22/06/26 | EUR 22.32 | +0.59% | 24,135 |
| 19/06/26 | EUR 22.19 | +0.23% | 7,746 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GSK Stock
- GS71 Stock
Select your edition
All financial news and data tailored to specific country editions
